Aster Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-433
Closed -$243K 1145
2025
Q4
$243K Sell
433
-23
-5% -$13.1K 0.11% 187
2025
Q3
$234K Sell
456
-192
-30% -$83.8K 0.12% 225
2025
Q2
$203K Sell
648
-864
-57% -$259K 0.05% 372
2025
Q1
$495K Buy
+1,512
New +$509K 0.09% 294

Other funds holding MEDP

Aster Capital Management's MEDP Position: Q1 2026 in Review

Aster Capital Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 433 shares — an estimated $243K sold.

Aster Capital Management first reported a position in MEDP in Q1 2025 and held it in 4 quarters. The position peaked at $495K in Q1 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Aster Capital Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 433 Medpace shares in Q1 2026, an estimated $243K.
  • Aster Capital Management first reported a position in Medpace in Q1 2025 and held it in 4 quarters.
  • Aster Capital Management's Medpace position peaked at $495K in Q1 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.